The Evolution of Liver Cancer Market in 2024
Speakers
Max Nisen
Analyst
Bloomberg Intelligence
Max Nisen is a senior associate equity research analyst specializing in the pharmaceutical and biotechnology sector. Prior to joining Bloomberg Intelligence, Max was the founding health care columnist for Bloomberg Gadfly and later Bloomberg Opinion, where he wrote about the pharmaceutical industry, managed care, policy and public health. Before that, he covered business and financial news at Quartz and Business Insider. Max earned a bachelor’s degree in economics from Pomona College.
Aude Gerspacher
Global Head of Healthcare
Bloomberg Intelligence
Aude Gerspacher is the Global Head of Healthcare Research at Bloomberg Intelligence. Prior to her current role, Ms. Gerspacher was the U.S. Director of Research for the regional equities team. She specializes in litigation and patent disputes in pharmaceuticals and biotechnology. Previously, Ms. Gerspacher worked as a Senior Corporate Counsel at Pfizer. Before transitioning in-house, Ms. Gerspacher worked as a patent attorney at Cozen O'Connor, a large full service law firm and Cooper & Dunham, a patent boutique firm in New York City. Ms. Gerspacher is a licensed patent attorney barred in the state of New York. She holds a bachelor of science in microbiology, a master of science in molecular biology and genetics, and a JD from Case Western University.